Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 304

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma

Open access
Robles, Ricardo, Figueras, Joan, Turrión, Victor S., Margarit, Carlos, Moya, Angel, Varo, Evaristo, Calleja, Javier, Valdivieso, Andres, Valdecasas, Juan Carlos G., López, Pedro, Gómez, Manuel, de Vicente, Emilio, Loinaz, Carmelo, Santoyo, Julio, Fleitas, Manuel, Bernardos, Angel, Lladó, Laura, Ramírez, Pablo, Bueno, F S., Jaurrieta, Eduardo, Parrilla, Pascual·2004·Annals of Surgery

Abstract

OBJECTIVE: To assess the real utility of orthotopic liver transplantation (OLT) in patients with cholangiocarcinoma, we need series with large numbers of cases and long follow-ups. The aim of this paper is to review the Spanish experience in OLT for hilar and peripheral cholangiocarcinoma and to try to identify the prognostic factors that could influence survival. SUMMARY BACKGROUND DATA: Palliative treatment of nondisseminated irresectable cholangiocarcinoma carries a zero 5-year survival rate. The role of OLT in these patients is controversial, due to the fact that the survival rate is lower than with other indications for transplantation and due to the lack of organs. METHODS: We retrospectively reviewed 59 patients undergoing OLT in Spain for cholangiocarcinoma (36 hilar and 23 peripheral) over a period of 13 years. We present the results and prognostic factors that influence survival. RESULTS: The actuarial survival rate for hilar cholangiocarcinoma at 1, 3, and 5 years was 82%, 53%, and 30%, and for peripheral cholangiocarcinoma 77%, 65%, and 42%. The main cause of death, with both types of cholangiocarcinoma, was tumor recurrence (present in 53% and 35% of patients, respectively). Poor prognosis factors were vascular invasion (P < 0.01) and IUAC classification stages III-IVA (P < 0.01) for hilar cholangiocarcinoma and perineural invasion (P < 0.05) and stages III-IVA (P < 0.05) for peripheral cholangiocarcinoma. CONCLUSIONS: OLT for nondisseminated irresectable cholangiocarcinoma has higher survival rates at 3 and 5 years than palliative treatments, especially with tumors in their initial stages, which means that more information is needed to help better select cholangiocarcinoma patients for transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.sla.0000108702.45715.81

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 304

Metadata

Authors
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., Gómez, M., de Vicente, E., Loinaz, C., Santoyo, J., Fleitas, M., Bernardos, A., Lladó, L., Ramírez, P., Bueno, F. S., Jaurrieta, E., & Parrilla, P.
Venue
Annals of Surgery
Published
2004-02
Volume
239
Issue
2
Pages
265-271
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2070793749
Cited by
304
References
18
FWCI
11.51
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma. https://app.cochat.ai/papers/10.1097/01.sla.0000108702.45715.81
The paper
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., Gómez, M., de Vicente, E., Loinaz, C., Santoyo, J., Fleitas, M., Bernardos, A., Lladó, L., Ramírez, P., Bueno, F. S., . . . Parrilla, P. (2004). Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma. Annals of Surgery. https://doi.org/10.1097/01.sla.0000108702.45715.81

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.